COVID-19 can produce yellow mucus, but yellow mucus is not a hallmark of the virus or a sign that something has gone especially wrong. The color change reflects your immune system’s activity in the nasal passages and airways, not the specific pathogen causing the infection. What makes COVID’s relationship with mucus interesting is less about the color itself and more about what the virus does to the nasal lining and how easily that damage sets the stage for complications.
Why Mucus Changes Color During Any Infection
Mucus in a healthy nose and throat is typically clear or slightly white. When your body detects a pathogen, it floods the area with white blood cells called neutrophils. These cells contain an enzyme called myeloperoxidase, which has a greenish tint. As neutrophils accumulate, break down, and mix with mucus, the secretions shift from clear to white, then to yellow, and sometimes to green. The color is essentially a stain left behind by your immune response doing its job.
A common assumption is that yellow or green mucus means bacteria are present. The reality is messier. A study of acute cough patients found that while yellowish or greenish sputum did correlate with bacterial infection, the test had poor specificity: only about 46% of the time did colored sputum actually indicate bacteria. Nearly four out of five bacterial infections did produce colored sputum, but more than half the people with colored sputum had no bacterial infection at all.1PubMed Central. Sputum colour for diagnosis of a bacterial infection in patients with acute cough In plain terms, colored mucus catches most bacterial infections but also flags a lot of viral ones. Color alone is an unreliable diagnostic tool.
That said, deepening color from yellow toward brownish shades has shown a stronger association with certain bacterial species in people with chronic lung disease, particularly gram-negative bacteria.2Respiratory Medicine. Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease The distinction matters: in someone with a pre-existing lung condition, dark or heavily purulent sputum carries more diagnostic weight than it does in someone fighting a typical respiratory virus.
How COVID Damages the Nasal Lining
SARS-CoV-2 targets cells in the nasal passages, and one consequence that researchers have documented in detail is severe disruption to the cilia, the tiny hair-like structures that sweep mucus out of your airways. Imaging of nasal tissue in COVID patients revealed that ciliary coverage dropped dramatically compared to healthy controls. Where healthy subjects had cilia covering roughly 57% of their nasal surface, COVID patients averaged about 18%. The beating frequency of the remaining cilia also fell significantly, and the normally rhythmic motion became erratic and irregular.3American Journal of Respiratory Cell and Molecular Biology. COVID-19 Causes Ciliary Dysfunction as Demonstrated by Human Intranasal Micro-Optical Coherence Tomography Imaging
This ciliary damage has real consequences for mucus. Normally, cilia work as a conveyor belt, continuously moving mucus toward the back of the throat where it can be swallowed harmlessly. When the conveyor belt breaks down, mucus pools and stagnates. Stagnant mucus thickens, traps more debris and dead immune cells, and is more likely to take on that yellow or greenish tint. It also creates pockets of low oxygen that can encourage bacterial growth. So while COVID itself can produce yellow mucus purely through vigorous immune activity and impaired clearance, the same stagnation also raises the risk that bacteria move in secondarily.
How Common Are Nasal Symptoms in COVID?
Runny nose and nasal congestion have always been part of COVID’s symptom profile, though they were not the dominant complaints in the original and Delta waves. A study of 120 COVID-19 patients documented nasal congestion in about 28%, nasal obstruction in roughly 27%, and runny nose in 20%.4PubMed Central. Analysis of Ear, Nose and Throat Manifestations in COVID-19 Patients Those rates are notable but substantially lower than what you’d see in a cold or flu. A systematic review comparing COVID-19, influenza, and the common cold found that runny nose appeared in only about 4% of COVID patients versus 91% of influenza patients and 81% of cold patients.5Advances in Clinical and Experimental Medicine. Comparison of the clinical differences between COVID-19, SARS, influenza, and the common cold: A systematic literature review
This difference matters for anyone trying to figure out what’s making them sick. If your main complaint is a river of yellow mucus with relatively little fever or muscle pain, the odds lean more toward a cold or flu than COVID, at least based on symptom profiles from the earlier waves. COVID’s signature has historically been more about fever, dry cough, fatigue, and loss of smell than about copious nasal discharge.
Omicron Changed the Nasal Symptom Picture
The arrival of Omicron shifted things. Research comparing Omicron and Delta found that Omicron replicated less efficiently in both lung and nasal tissue than earlier variants, based on animal model data. This reduced replication in nasal tissue may explain why loss of smell became less common with Omicron.6PubMed Central. Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B.1.1.529) and Delta (B.1.617.2) from routine contact tracing data in England But clinically, many people noticed the opposite effect on congestion: Omicron infections tended to behave more like upper respiratory infections, with sore throat, runny nose, and sneezing taking center stage. That means people infected with more recent variants are probably more likely to experience noticeable mucus production, including yellow mucus, than people who had the original strain.
The practical upshot is that using nasal symptoms to tell COVID apart from a cold has become harder with each passing variant. If you’re congested and blowing yellow mucus in 2024 or 2025, the symptom overlap between COVID, flu, and a common cold is large enough that a test is the only reliable way to know which virus you’re dealing with.
Yellow Mucus Does Not Mean You Need Antibiotics
This is probably the single most important takeaway in the entire topic, and it applies whether you have COVID, a cold, flu, or any other upper respiratory infection. Yellow or green mucus prompts antibiotic prescriptions at far higher rates than clear mucus, but the evidence that antibiotics help in these cases is weak to nonexistent for most patients.
A large observational study of general practitioners found that yellow sputum roughly doubled the odds of receiving an antibiotic prescription.7PubMed Central. Influence of patient symptoms and physical findings on general practitioners’ treatment of respiratory tract infections: a direct observation study Another analysis showed that patients producing discolored sputum were about three times more likely to be prescribed antibiotics than patients not producing sputum at all. But here’s the critical finding: antibiotic prescriptions did not lead to faster symptom improvement in patients with yellow or green sputum compared to those who didn’t get antibiotics.8PubMed. Antibiotic prescribing for discoloured sputum in acute cough/lower respiratory tract infection The color of the mucus simply wasn’t a reliable predictor of who would benefit from antibiotic treatment.
Researchers have noted for years that efforts to reduce unnecessary antibiotic use should specifically address clinicians’ tendency to treat purulent secretions as if they indicate bacterial infection.9PubMed Central. The relation between purulent manifestations and antibiotic treatment of upper respiratory tract infections During the COVID pandemic, this issue became particularly acute because many patients and clinicians worried that yellow or green mucus during COVID meant a bacterial co-infection requiring antibiotics. In most cases, it didn’t.
When a Secondary Bacterial Infection Is a Real Concern
That said, secondary bacterial infections do happen in COVID patients, and they matter. Among hospitalized COVID patients in one study, about a quarter developed a possible or proven secondary infection during their hospital stay. The risk factors that stood out were transfer from another hospital, use of immunosuppressant drugs, and treatment with corticosteroids.10Infection Control & Hospital Epidemiology. Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19)
The distinction to keep in mind is between hospitalized patients and people managing COVID at home. If you’re recovering from a mild or moderate case at home and your mucus turns yellow for a few days before gradually clearing, that’s the standard immune response at work. Warning signs that something more is happening include:
- Worsening after improvement: You start feeling better, then suddenly feel worse again, with new fever and thicker discharge.
- Prolonged symptoms: Yellow or green mucus persisting well beyond ten days without improvement.
- Facial pain and pressure: Concentrated around the sinuses, suggesting the stagnant mucus has led to a bacterial sinus infection.
- High or returning fever: A new spike in temperature after several days of illness suggests a secondary process.
These patterns suggest bacteria may have colonized the mucus that COVID’s ciliary damage left sitting in your sinuses or airways. In those cases, antibiotics may genuinely be warranted, unlike in the early days of a viral infection when colored mucus is just your immune system working.
What You Can Do About Thick, Colored Mucus
If you’re dealing with yellow mucus from COVID and want relief, saline nasal irrigation is the intervention with the most supporting evidence. Rinsing the nasal passages with saline helps on multiple fronts: it hydrates the periciliary layer, loosens thick mucus, and physically washes out the accumulated debris, dead cells, and mucus plugs that COVID’s ciliary damage leaves behind.11Frontiers in Public Health. Saline nasal irrigation and gargling in COVID-19: a multidisciplinary review of effects on viral load, mucosal dynamics, and patient outcomes Saline also promotes ciliary beating and improves mucociliary clearance, essentially doing some of the work that your damaged cilia can’t.12PubMed Central. Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19
From a COVID-specific standpoint, researchers have noted that the virus triggers exaggerated mucus production, making clearance all the more important. Repetitive rinsing with large volumes of isotonic saline has been suggested as a preferred approach because the sheer volume helps dislodge the adhesive mucus plugs that form during infection.13Frontiers in Public Health. Saline nasal irrigation and gargling in COVID-19: Part II. Outcomes in Omicron and risk–benefit for self-care Hypertonic saline, which has a higher salt concentration, may be even more effective at reducing secretions and improving mucociliary transport compared to isotonic solutions, based on pooled data from chronic rhinosinusitis patients.14Brazilian Journal of Otorhinolaryngology. Efficacy of nasal irrigation with hypertonic saline on chronic rhinosinusitis: systematic review and meta-analysis That last finding comes from chronic sinus disease rather than acute COVID, but the underlying mechanics of thinning mucus and boosting clearance apply to any situation where thick secretions are pooling.
Beyond saline rinses, the usual supportive measures apply: staying well hydrated, using a humidifier to keep air moist, and avoiding irritants like cigarette smoke that further impair ciliary function. Over-the-counter decongestants can help short-term, but nasal spray decongestants shouldn’t be used for more than a few days to avoid rebound congestion.
How COVID Reshapes the Bacteria Already in Your Nose
One of the more interesting findings in recent years is that SARS-CoV-2 infection doesn’t just damage tissue and slow down mucus clearance; it also changes which bacteria live in your nasal passages. Research comparing the nasal microbiome of COVID-positive patients with uninfected controls found a distinct bacterial profile in infected individuals, marked by an increased abundance of potentially harmful bacteria, including Pseudomonas aeruginosa, a species known for causing difficult-to-treat infections. The abundance of this bacterium was positively correlated with viral load.15PubMed Central. Acute SARS-CoV-2 infection is associated with an increased abundance of bacterial pathogens, including Pseudomonas aeruginosa in the nose
This microbiome disruption likely feeds back into mucus quality and color. When pathogenic bacteria flourish in the nasal passages, they attract more neutrophils, generate more cellular debris, and contribute to the yellowish or greenish tint of secretions. The shift also raises the stakes for secondary infections: a nose populated with more aggressive bacteria is a nose more primed for a genuine bacterial sinus infection if mucus clearance stays impaired long enough.
The research also runs in the other direction. A study published in eBioMedicine found that the composition of someone’s nasal microbiome before infection influenced their susceptibility to COVID in the first place. High densities of certain common bacteria like Staphylococcus aureus and Haemophilus influenzae were linked to increased expression of the receptors SARS-CoV-2 uses to enter cells, while a bacterium called Dolosigranulum pigrum was associated with lower expression of those receptors.16eBioMedicine. Nasal ACE2 and TMPRSS2 expression and nasal microbiome predict SARS-CoV-2 infection risk in adults This research is still in early stages, but it raises the possibility that modifying the nasal microbiome could someday be a strategy for reducing COVID risk. Separate research has also shown that differences in the nasal microbiome distinguished COVID patients who recovered from those who died, suggesting the bacterial community in the nose may influence disease outcomes as well.17PubMed Central. Nasopharyngeal microbiome of COVID-19 patients revealed a distinct bacterial profile in deceased and recovered individuals
Reading Your Mucus in Context
If there’s a thread running through the research, it’s that mucus color is a crude signal. Yellow mucus during COVID tells you your immune system has shown up, which is what you want it to do. It does not tell you whether bacteria are involved, whether you need antibiotics, or whether your case is more serious than someone else’s. The far more useful signals are the trajectory of your symptoms, whether you’re getting better or worse over time, and whether new symptoms like high fever or facial pain appear after initial improvement.
For people who are otherwise healthy and managing COVID at home, yellow mucus for a week or so is normal and expected, especially given what the virus does to ciliary function and mucus clearance. The color usually shifts back toward clear or white as the immune response winds down and the cilia begin to recover. Keeping the nasal passages irrigated with saline can speed that process along and provide meaningful comfort in the meantime. Save the worry for the pattern shifts mentioned earlier, and save the antibiotics for cases where a clinician has reason to suspect a genuine secondary bacterial infection rather than just the immune system’s messy handiwork.